This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n7http://dx.doi.org/10.4088/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37759333
rdf:type
wikibase:Item
schema:description
scientific article published on May 2010 bilimsel makale vetenskaplig artikel artículu científicu espublizáu en 2010 مقالة علمية نشرت في مايو 2010 наукова стаття, опублікована в травні 2010 vědecký článek article científic articolo scientifico article scientifique artigo científico vedecký článok wissenschaftlicher Artikel научни чланак wetenschappelijk artikel videnskabelig artikel
p:P577
wds:Q37759333-640C70C0-1643-4F37-9259-1C583FDB042B
wdt:P577
2010-05-01T00:00:00Z
rdfs:label
Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium
skos:prefLabel
Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium
schema:name
Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium
p:P50
wds:Q37759333-A5B780AC-0868-42BC-8D48-3033B1638048
wdt:P50
wd:Q43089666
p:P1476
wds:Q37759333-078DACCD-29E9-45BB-9CC7-6B1AEDE64191
wdt:P1476
Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium
p:P304
wds:Q37759333-4B5FFBC6-E483-49D9-B283-AEE6BB8D1AAD
wdt:P304
649-650
p:P31
wds:Q37759333-A5120747-FC73-49EB-944D-219AAC79BEF3 wds:Q37759333-7829ebd3-889c-4a70-9e91-8f46db50a1af
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q37759333-9034133B-A4C8-4E60-A51C-70BFCBA4ED50 wds:Q37759333-2B016C71-A281-4315-B420-BEC4B6ED0975 wds:Q37759333-2BA2DF06-B9AC-4961-BCF3-6665756867DF
wdt:P921
wd:Q749115 wd:Q11995 wd:Q410346
p:P698
wds:Q37759333-F0CE3A55-EBDE-4D42-81EE-5BB8FFCC334A
wdtn:P698
n8:20492855
wdt:P698
20492855
p:P1433
wds:Q37759333-332BEAF0-C95B-48D7-B3E3-783E94F8A9DF
wdt:P1433
wd:Q7743563
p:P433
wds:Q37759333-B97B0AF1-9EED-4740-9A29-E102A9104BB5
p:P478
wds:Q37759333-0C3ABAB4-CF00-4CA3-B998-A61343C01296
wdt:P433
5
wdt:P478
71
p:P356
wds:Q37759333-1932069D-181A-4CC0-9BFE-B6251B859725
wdtn:P356
n7:JCP.10AC06132GRE
wdt:P356
10.4088/JCP.10AC06132GRE